178 related articles for article (PubMed ID: 32632107)
21. Inhibition of Class I Histone Deacetylases 1 and 2 Promotes Urothelial Carcinoma Cell Death by Various Mechanisms.
Pinkerneil M; Hoffmann MJ; Deenen R; Köhrer K; Arent T; Schulz WA; Niegisch G
Mol Cancer Ther; 2016 Feb; 15(2):299-312. PubMed ID: 26772204
[TBL] [Abstract][Full Text] [Related]
22. Multienzyme interactions of the de novo purine biosynthetic protein PAICS facilitate purinosome formation and metabolic channeling.
He J; Zou LN; Pareek V; Benkovic SJ
J Biol Chem; 2022 May; 298(5):101853. PubMed ID: 35331738
[TBL] [Abstract][Full Text] [Related]
23. The role of HDAC2 in chromatin remodelling and response to chemotherapy in ovarian cancer.
Huang R; Langdon SP; Tse M; Mullen P; Um IH; Faratian D; Harrison DJ
Oncotarget; 2016 Jan; 7(4):4695-711. PubMed ID: 26683361
[TBL] [Abstract][Full Text] [Related]
24. PAICS, a Purine Nucleotide Metabolic Enzyme, is Involved in Tumor Growth and the Metastasis of Colorectal Cancer.
Agarwal S; Chakravarthi BVSK; Behring M; Kim HG; Chandrashekar DS; Gupta N; Bajpai P; Elkholy A; Balasubramanya SAH; Hardy C; Diffalha SA; Varambally S; Manne U
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32218208
[TBL] [Abstract][Full Text] [Related]
25. Weighted gene co-expression network analysis and connectivity map identifies lovastatin as a treatment option of gastric cancer by inhibiting HDAC2.
Zhang L; Kang W; Lu X; Ma S; Dong L; Zou B
Gene; 2019 Jan; 681():15-25. PubMed ID: 30266498
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial GRIM-19 as a potential therapeutic target for STAT3-dependent carcinogenesis of gastric cancer.
Huang Y; Yang M; Hu H; Zhao X; Bao L; Huang D; Song L; Li Y
Oncotarget; 2016 Jul; 7(27):41404-41420. PubMed ID: 27167343
[TBL] [Abstract][Full Text] [Related]
27. Histone deacetylase (HDAC) 1 and 2 expression and chemotherapy in gastric cancer.
Mutze K; Langer R; Becker K; Ott K; Novotny A; Luber B; Hapfelmeier A; Göttlicher M; Höfler H; Keller G
Ann Surg Oncol; 2010 Dec; 17(12):3336-43. PubMed ID: 20585871
[TBL] [Abstract][Full Text] [Related]
28. PIEZO1 functions as a potential oncogene by promoting cell proliferation and migration in gastric carcinogenesis.
Zhang J; Zhou Y; Huang T; Wu F; Liu L; Kwan JSH; Cheng ASL; Yu J; To KF; Kang W
Mol Carcinog; 2018 Sep; 57(9):1144-1155. PubMed ID: 29683214
[TBL] [Abstract][Full Text] [Related]
29. Distinct Roles for Intestinal Epithelial Cell-Specific Hdac1 and Hdac2 in the Regulation of Murine Intestinal Homeostasis.
Gonneaud A; Turgeon N; Boudreau F; Perreault N; Rivard N; Asselin C
J Cell Physiol; 2016 Feb; 231(2):436-48. PubMed ID: 26174178
[TBL] [Abstract][Full Text] [Related]
30. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
Zhou J; Chen Q
FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
[TBL] [Abstract][Full Text] [Related]
31. Ubiquitin specific peptidase 5 promotes ovarian cancer cell proliferation through deubiquitinating HDAC2.
Du Y; Lin J; Zhang R; Yang W; Quan H; Zang L; Han Y; Li B; Sun H; Wu J
Aging (Albany NY); 2019 Nov; 11(21):9778-9793. PubMed ID: 31727867
[TBL] [Abstract][Full Text] [Related]
32. HDAC1 and HDAC2 independently predict mortality in hepatocellular carcinoma by a competing risk regression model in a Southeast Asian population.
Ler SY; Leung CH; Khin LW; Lu GD; Salto-Tellez M; Hartman M; Iau PT; Yap CT; Hooi SC
Oncol Rep; 2015 Nov; 34(5):2238-50. PubMed ID: 26352599
[TBL] [Abstract][Full Text] [Related]
33. Targeted inactivation of HDAC2 restores p16INK4a activity and exerts antitumor effects on human gastric cancer.
Kim JK; Noh JH; Eun JW; Jung KH; Bae HJ; Shen Q; Kim MG; Chang YG; Kim SJ; Park WS; Lee JY; Borlak J; Nam SW
Mol Cancer Res; 2013 Jan; 11(1):62-73. PubMed ID: 23175521
[TBL] [Abstract][Full Text] [Related]
34. PAICS as a potential target for cancer therapy linking purine biosynthesis to cancer progression.
Huo A; Xiong X
Life Sci; 2023 Oct; 331():122070. PubMed ID: 37673296
[TBL] [Abstract][Full Text] [Related]
35. Suppression of fumarate hydratase activity increases the efficacy of cisplatin-mediated chemotherapy in gastric cancer.
Yu HE; Wang F; Yu F; Zeng ZL; Wang Y; Lu YX; Jin Y; Wang DS; Qiu MZ; Pu HY; Kang TB; Xie D; Ju HQ; Xu RH; Luo HY
Cell Death Dis; 2019 May; 10(6):413. PubMed ID: 31138787
[TBL] [Abstract][Full Text] [Related]
36. Histone methyltransferase SETD1A interacts with HIF1α to enhance glycolysis and promote cancer progression in gastric cancer.
Wu J; Chai H; Xu X; Yu J; Gu Y
Mol Oncol; 2020 Jun; 14(6):1397-1409. PubMed ID: 32291851
[TBL] [Abstract][Full Text] [Related]
37. Generation of a Rat Monoclonal Antibody for Human PAICS, a
Yokoyama C; Bando K; Yamagata M; Nagasaki T; Tachibana T
Monoclon Antib Immunodiagn Immunother; 2024 Jun; ():. PubMed ID: 38836825
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
[TBL] [Abstract][Full Text] [Related]
39. CDCA3 is a potential prognostic marker that promotes cell proliferation in gastric cancer.
Zhang Y; Yin W; Cao W; Chen P; Bian L; Ni Q
Oncol Rep; 2019 Apr; 41(4):2471-2481. PubMed ID: 30816466
[TBL] [Abstract][Full Text] [Related]
40. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
